Welcome to the new version of CaltechAUTHORS. Login is currently restricted to library staff. If you notice any issues, please email coda@library.caltech.edu
Published April 2013 | Supplemental Material + Published
Journal Article Open

Structural basis for high-affinity binding of LEDGF PWWP to mononucleosomes

Abstract

Lens epithelium-derived growth factor (LEDGF/p75) tethers lentiviral preintegration complexes (PICs) to chromatin and is essential for effective HIV-1 replication. LEDGF/p75 interactions with lentiviral integrases are well characterized, but the structural basis for how LEDGF/p75 engages chromatin is unknown. We demonstrate that cellular LEDGF/p75 is tightly bound to mononucleosomes (MNs). Our proteomic experiments indicate that this interaction is direct and not mediated by other cellular factors. We determined the solution structure of LEDGF PWWP and monitored binding to the histone H3 tail containing trimethylated Lys36 (H3K36me3) and DNA by NMR. Results reveal two distinct functional interfaces of LEDGF PWWP: a well-defined hydrophobic cavity, which selectively interacts with the H3K36me3 peptide and adjacent basic surface, which non-specifically binds DNA. LEDGF PWWP exhibits nanomolar binding affinity to purified native MNs, but displays markedly lower affinities for the isolated H3K36me3 peptide and DNA. Furthermore, we show that LEDGF PWWP preferentially and tightly binds to in vitro reconstituted MNs containing a tri-methyl-lysine analogue at position 36 of H3 and not to their unmodified counterparts. We conclude that cooperative binding of the hydrophobic cavity and basic surface to the cognate histone peptide and DNA wrapped in MNs is essential for high-affinity binding to chromatin.

Additional Information

© The Author(s) 2013. Published by Oxford University Press. This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/licenses/ by-nc/3.0/), which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited. Received October 9, 2012; Revised December 27, 2012; Accepted January 18, 2013. First published online: February 8, 2013. We wish to thank Julian W. Bess, Jr., Rodman B. Smith, William H. Bohn and David B. Westcott of the AIDS and Cancer Virus Program, Biological Products Core, for producing the SupT1 cells for this study. We also thank Jacques Kessl, Ross Larue and Amit Sharma for critical reading of the manuscript. Funding: National Institutes of Health [AI062520 and GM103368 to M.K., GM077234 to M.P.F.]; National Cancer Institute, National Institutes of Health [under contract HHSN261200800001E with SAIC-Frederick, Inc. (to R.J.G.)]. The content of this publication does not necessarily reflect the views or policies of the Department of Health and Human Services, nor does mention of trade names, commercial products, or organizations imply endorsement by the U. S. Government. Funding for open access charge: National Institutes of Health [GM103368].

Attached Files

Published - Nucl._Acids_Res.-2013-Eidahl-3924-36.pdf

Supplemental Material - A9RD3D4.pdf

Files

Nucl._Acids_Res.-2013-Eidahl-3924-36.pdf
Files (11.4 MB)
Name Size Download all
md5:811cc7883a0da819043d2de41e010ce0
7.8 MB Preview Download
md5:006d45158ce032ae35f295dcd5046a7b
3.6 MB Preview Download

Additional details

Created:
August 19, 2023
Modified:
October 24, 2023